Article
Insights into SARS-CoV-2's Mutations for Evading Human Antibodies: Sacrifice and Survival.
Journal of medicinal chemistry - 24 Feb 2022
Luan Binquan, Huynh Tien
Abstract excerpt
The highly infectious SARS-CoV-2 variant B.1.351 that first emerged in South Africa with triple mutations (N501Y, K417N, and E484K) is globally worrisome. It is known that N501Y and E484K can enhance binding between the coronavirus receptor domain (RBD) and human ACE2. However, the K417N mutation appears to be unfavorable as it removes one interfacial salt bridge. Here, we show that despite the decrease in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
